메뉴 건너뛰기




Volumn 19, Issue 4, 2015, Pages 412-413

Glucose-Lowering Effect of Sevelamer Hydrochloride in Hemodialysis Patients

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HEMOGLOBIN A1C; NITROGEN; PHOSPHATE; SEVELAMER; UREA; ANTIDIABETIC AGENT; CHELATING AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; SERUM ALBUMIN;

EID: 84941890192     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12284     Document Type: Letter
Times cited : (2)

References (4)
  • 2
    • 84862223183 scopus 로고    scopus 로고
    • Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease
    • Vlassara H, Uribarri J, Cai W etal. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease. Clin J Am Soc Nephrol 2012;7:934-942.
    • (2012) Clin J Am Soc Nephrol , vol.7 , pp. 934-942
    • Vlassara, H.1    Uribarri, J.2    Cai, W.3
  • 3
    • 80052142793 scopus 로고    scopus 로고
    • Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1
    • Uribarri J, Cai W, Ramdas M etal. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 2011;34:1610-1616.
    • (2011) Diabetes Care , vol.34 , pp. 1610-1616
    • Uribarri, J.1    Cai, W.2    Ramdas, M.3
  • 4
    • 79959785811 scopus 로고    scopus 로고
    • Role of bile acid sequestrants in the treatment of type 2 diabetes
    • Handelsman Y. Role of bile acid sequestrants in the treatment of type 2 diabetes. Diabetes Care 2011;34(Suppl 2):S244-250.
    • (2011) Diabetes Care , vol.34 , pp. S244-S250
    • Handelsman, Y.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.